Simultaneous determination of midazolam and its metabolites 1-hydroxymidazolam and 4-hydroxymidazolam in human serum using gas chromatography-mass spectrometry.
A method for the quantitation of midazolam and its metabolites 1-hydroxymidazolam and 4-hydroxymidazolam from human serum capable of monitoring concentrations achieved under therapeutic conditions is presented. The substances were extracted under basic conditions with toluene and the hydroxy metabolites transformed to their tert-butyldimethylsilyl derivatives with N-(tert-butyldimethylsilyl)-N-methyltrifluoroacetamide. The samples were measured by gas chromatography-mass spectrometry. The limits of detection are 0.2 ng ml(-1) for midazolam and 0.1 ng ml(-1) for 1-hydroxy- and 4-hydroxymidazolam. The coefficients of variation are 3.9% at 5 ng ml(-1) for midazolam, 6.7% at 2 ng ml(-1) for 1-hydroxymidazolam and 8.8% (22.2%) at 0.5 (0.2) ng ml(-1) for 4-hydroxymidazolam.
Martens
J
J
Otto von Guericke Universität Magdeburg, Medizinische Fakultät, Institut für Klinische Pharmakologie, Germany.
Banditt
P
P
D018686:Anesthetics, Intravenous / Q000097:blood*; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D006993:Hypnotics and Sedatives / Q000097:blood*; D008874:Midazolam / Q000031:analogs & derivatives* / Q000097:blood*; D012680:Sensitivity and Specificity
D018686:Anesthetics, Intravenous; D006993:Hypnotics and Sedatives; C042940:4-hydroxymidazolam; C040081:1-hydroxymethylmidazolam; D008874:Midazolam